Reglan: Clinical Trials

26 trials of Reglan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 5 terminated, 3 unknown, 3 withdrawn. 12 Phase 4, 9 Phase 2, 3 Not applicable, 3 Phase 3, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 412Completed 5, Terminated 3, Not yet recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1
Phase 29Completed 7, Terminated 1, Withdrawn 1
Not applicable3Completed 1, Unknown 1, Withdrawn 1
Phase 33Terminated 1, Unknown 1, Withdrawn 1
Phase 12Completed 2

Follow Reglan: new trials by email Literature Review of Reglan trials Research Report on Reglan

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and Metoclopramide
Fosaprepitant for Injection, Metoclopramide Injection - Nausea and Vomiting, Nausea
Phase 4Not yet recruitingMontefiore Medical Center2122026-12-012026-06-29
Time to First Rescue Antiemetic With Ondansetron Plus Metoclopramide Versus Dexamethasone Plus Metoclopramide for PONV Prophylaxis in Laparoscopic Cholecystectomy
ondansetron 4 mg, Dexamethasone (intravenous), Metoclopramide 10mg - Postoperative Nausea and Vomiting
Phase 4RecruitingFaisalabad Medical University2642026-09-012026-09-04
Metoclopramide in Upper Gastrointestinal Bleed
Metoclopramide 10mg, Saline - Upper GI Bleeding, Bleeds Gastric
Phase 4UnknownMercy Health System602023-05-202023-07-11
Capsaicin Cream as an Adjunctive Therapy for Nausea and Vomiting of Pregnancy
Capsaicin Topical Cream, Metoclopramide, Ondansetron - Hyperemesis Gravidarum, Nausea Gravidarum
Phase 2CompletedWomen and Infants Hospital of Rhode Island302022-05-242024-02-07
PROUD Study - Preventing Opioid Use Disorders
Guided mindfulness exercises, Self-administered aromatherapy, Baby aspirin - Anesthesia, Opioid Use
Phase 4TerminatedEmory University572021-05-172023-06-22
Metoclopramide Versus Placebo for GJ Placement
Metoclopramide 5 MG/ML Injectable Solution, Saline - Radiation Exposure, Enteral Nutrition
Phase 2CompletedDuke University1102018-04-092020-07-13
Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy
Aprepitant 80 mg Oral Capsule, scopolamine transdermal, Total intravenous anesthesia - Post-operative Nausea and Vomiting, Laparoscopic Sleeve Gastrectomy
Phase 4CompletedStony Brook University832017-08-282024-02-14
Metoclopramide for Post-Traumatic Headache. A Pilot Study
Metoclopramide, Diphenhydramine - Post-Traumatic Headache
Phase 1 / Phase 2CompletedMontefiore Medical Center212017-03-012018-07-31
Study to Evaluate the Effect of Aprepitant in Children and Adolescents Receiving AML Remission Induction Chemotherapy
Aprepitant, Ondansetron, Metoclopramide - Chemotherapy Induced Vomiting, Acute Myeloid Leukemia
Phase 3UnknownDr Atul Sharma1162016-11-012017-01-25
Auricular Acupuncture vs SOC in Migraine HA
Auricular Acupuncture, Ketorolac 0.5mg/kg, max 30mg, Metoclopramide 0.1 mg/kg, max 10mg - Migraine Headache
Not applicableUnknownUniversity of Louisville802016-02-012023-10-10
Acupuncture Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean
Acupressure Point P6 stimulator, Metoclopramide, Ondansetron - Nausea, Vomiting
Phase 4CompletedRutgers, The State University of New Jersey1802015-07-012017-09-25
PEP uP Protocol in Surgical Patients
PEP uP Protocol, Metoclopramide - Critically Ill
Phase 4TerminatedClinical Evaluation Research Unit at Kingston General Hospital362015-07-012020-10-27
Comparison of Gabapentin and Metoclopramide for Treating Hyperemesis Gravidarum
Gabapentin, Metoclopramide - Hyperemesis Gravidarum
Phase 2CompletedState University of New York at Buffalo312014-06-012023-02-14
Efficacy of Haloperidol vs. Metoclopramide for Treatment of Acute Headaches and Migraines in the Emergency Department
Metoclopramide, Haloperidol, Normal Saline - Headache, Migraine
Phase 4TerminatedOhioHealth662014-02-012018-10-23
Bupivacaine for Benign Headache in the ED
0.5% bupivacaine, Standard Care - Benign Headache
Phase 2TerminatedWake Forest University Health Sciences232013-10-012022-07-14
TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas
TRC102, CT scan, Lomotil - Lymphomas, Solid Tumors
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)932013-07-122024-05-08
Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the ED: A RCT
Haloperidol, Metoclopramide 10mg, Diphenhydramine - Migraine Headaches, Nausea
Phase 4WithdrawnUnited States Naval Medical Center, Portsmouth2013-06-122025-07-29
Diphenhydramine for Acute Migraine
metoclopramide, diphenhydramine, placebo - Migraine
Phase 4CompletedMontefiore Medical Center2082013-04-012018-07-31
Comparison of Metoclopramide and Ibuprofen for the Treatment of Acute Mountain Sickness
Ibuprofen, Metoclopramide - Acute Mountain Sickness, High Altitude Headache
Not applicableCompletedMassachusetts General Hospital3002012-03-012020-09-02
Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department
Ketorolac Tromethamine, Metoclopramide - Probable Migraine, Migraine With Aura
Phase 4CompletedUniversity of Alberta562012-02-012015-01-26

Showing 20 of 26. Sign in to see all of them.

Conditions studied

Migraine Disorders (7)  ·  Nausea (5)  ·  Vomiting (5)  ·  Headache (4)  ·  Hyperemesis Gravidarum (2)  ·  Altitude Sickness (1)  ·  Colonic Neoplasms (1)  ·  Critical Illness (1)  ·  Diabetes Mellitus (1)  ·  Emergencies (1)  ·  Feeding and Eating Disorders (1)  ·  Gastrointestinal Hemorrhage (1)  ·  Gastroparesis (1)  ·  Hemorrhage (1)  ·  Leukemia, Myeloid, Acute (1)

Sponsors

Montefiore Medical Center (4)  ·  Women and Infants Hospital of Rhode Island (2)  ·  Children's Hospital of Philadelphia (1)  ·  Clinical Evaluation Research Unit at Kingston General Hospital (1)  ·  Dr Atul Sharma (1)  ·  Duke University (1)  ·  East Tennessee State University (1)  ·  Emory University (1)  ·  Evoke Pharma (1)  ·  Faisalabad Medical University (1)  ·  Massachusetts General Hospital (1)  ·  Mercy Health System (1)  ·  Michael Dean (1)  ·  National Cancer Institute (NCI) (1)  ·  OhioHealth (1)

Countries

United States (22)  ·  Canada (1)  ·  India (1)  ·  Nepal (1)  ·  Pakistan (1)

Top investigators

Alice P Chen, M.D. (1)  ·  Asifa Saeed, MBBS; FCPS (1)  ·  Benjamin Friedman, MD (1)  ·  Benjamin W Friedman (1)  ·  Carey Nichols, MD (1)  ·  Christopher Lloyd, D.O. (1)  ·  Daren K Heyland, MD (1)  ·  Darshan S Shah, MD (1)  ·  James Ronald (1)  ·  Janice Sullivan, MD (1)  ·  Joseph Carcillo, MD (1)  ·  Konstantinos Spaniolas, MD (1)  ·  Lauren Murphy, MD (1)  ·  Lawrence P. Richer, MD, MSc (1)  ·  Matthew Gaffigan, MD (1)

Results publications

PMID 22079954, PMID 23567060, PMID 25576687, PMID 26320523, PMID 32457012, PMID 33122168, PMID 33451591, PMID 33528788, PMID 34002866, PMID 37271593

NIH funding

R01HD076313 (1)